ストックスクリーナーアプリを入手
28.86
1.14%
0.325
前日終値:
$28.53
開ける：
$28.52
24時間の取引高:
125.08K
Relative Volume:
0.25
時価総額：
$1.20B
収益：
$384.90M
当期純損益:
$-851.00K
株価収益率:
-1,442.75
EPS:
-0.02
ネットキャッシュフロー:
$12.83M
1週間 パフォーマンス:
+23.68%
1か月 パフォーマンス:
+20.48%
6か月 パフォーマンス:
+0.51%
1年 パフォーマンス:
+23.31%
1日の値動き範囲:
$28.27
$28.96
1週間の範囲:
$23.14
$29.12
52週間の値動き範囲:
$21.97
$32.33
Artivion Inc Stock (AORT) Company Profile
AORT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
28.86 | 1.20B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
134.41 | 227.71B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.06 | 152.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.35 | 142.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.99 | 107.17B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.95 | 44.04B | 5.54B | 4.18B | 623.10M | 7.00 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-09-27 | 繰り返されました | Lake Street | Buy |
| 2022-08-08 | 開始されました | Lake Street | Buy |
| 2022-03-03 | 開始されました | Stifel | Buy |
Artivion Inc (AORT) 最新ニュース
Artivion, Inc.'s (NYSE:AORT) 29% Jump Shows Its Popularity With Investors - simplywall.st
Artivion (NYSE:AORT) Raised to “Strong-Buy” at Citizens Jmp - Defense World
Artivion, Inc. (NYSE:AORT) Q1 2025 Earnings Call Transcript - MSN
Artivion revenue increases 2% to USD 99M in Q1 2025 - Medical Buyer
Artivion’s Earnings Call: Optimism Amid Challenges - TipRanks
ARTIVION, INC. SEC 10-Q Report - TradingView
Artivion (AORT) Maintains Market Outperform Rating by JMP Securities | AORT Stock News - GuruFocus
JMP maintains Artivion stock Market Outperform, $33 target - Investing.com
What Analysts Are Saying About Artivion Stock - Benzinga
Artivion, Inc.'s (NYSE:AORT) CEO Looks Like They Deserve Their Pay Packet - simplywall.st
Artivion (AORT) Receives Reiteration of 'Buy' Rating from Needha - GuruFocus
Artivion (AORT) Receives Reiteration of 'Buy' Rating from Needham | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS - GuruFocus
Stifel maintains Artivion stock Buy rating, $30 target amid growth By Investing.com - Investing.com India
Stifel maintains Artivion stock Buy rating, $30 target amid growth - Investing.com
Artivion Inc. Reports Q1 2025 Financial Results - TipRanks
Artivion Inc (AORT) Q1 2025 Earnings Call Highlights: Strong Product Growth Amid Cybersecurity ... - Yahoo Finance
Artivion (AORT) Reports Q1 2025 Growth and Raises Full-Year Guid - GuruFocus
Artivion: Q1 Earnings Snapshot - MySA
Artivion Inc (AORT) Q1 2025 Earnings: EPS of $(0.01) Beats Estimate, Revenue Surpasses Expectations at $99 Million - GuruFocus
Earnings call transcript: Artivion Q1 2025 revenue misses forecast, stock rises - Investing.com
Artivion (AORT) Lags Q1 Earnings Estimates - Yahoo Finance
Artivion Q1 2025 slides: Revenue grows 4% as cyber incident recovery accelerates - Investing.com India
Artivion’s (NYSE:AORT) Q1: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Artivion (AORT) Raises Revenue Outlook for 2025 | AORT Stock New - GuruFocus
Artivion Reports First Quarter 2025 Financial Results | AORT Sto - GuruFocus
Artivion earnings beat by $0.06, revenue fell short of estimates - Investing.com UK
Artivion Reports First Quarter 2025 Financial Results - Star Local Media
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomp - GuruFocus
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomphe Trial | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - PR Newswire
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Artivion (AORT) to Release Quarterly Earnings on Monday - Defense World
Artivion: Q4 Earnings Snapshot - Barchart.com
Artivion Inc (AORT) Q1 2025 Earnings Report Preview: What To Loo - GuruFocus
Wells Fargo & Company MN Buys 6,299 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) rises 5.3% this week, taking three-year gains to 16% - simplywall.st
LPL Financial LLC Grows Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results | AORT Stock News - GuruFocus
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - Kilgore News Herald
JPMorgan Chase & Co. Increases Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Sold by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Buys 600 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Russell Investments Group Ltd. Acquires 16,720 Shares of Artivion, Inc. (NYSE:AORT) - The AM Reporter
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year - Yahoo Finance
Arrowstreet Capital Limited Partnership Invests $288,000 in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Purchased by Vanguard Group Inc. - Defense World
Raymond James Financial Inc. Buys New Shares in Artivion, Inc. (NYSE:AORT) - Defense World
Strength Seen in Artivion (AORT): Can Its 7.9% Jump Turn into More Strength? - Nasdaq
Artivion, Inc. (NYSE:AORT) Shares Acquired by American Century Companies Inc. - Defense World
Artivion Inc (AORT) 財務データ
収益
当期純利益
現金流量
EPS
1.26%
0.84%
大文字化:
|
ボリューム (24 時間):